Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01709552 · ClinicalTrials.gov registry record · NA

Brief Intervention for Substance Use and Partner Abuse Among Females in the ER

A NA study of Substance-Related Disorders and Domestic Violence, sponsored by Rhode Island Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT01709552 is a NA study of Substance-Related Disorders and Domestic Violence that has completed, run by Rhode Island Hospital. The registered enrollment target is 40 participants, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01709552, a NA study of Substance-Related Disorders and Domestic Violence, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to target co-occurring problems of substance use and intimate partner violence (IPV) using a computer-based intervention, B-SAFER (Brief intervention for Substance use and partner Abuse for Females in the Emergency Room). This project will develop and test the computer-based intervention, examining primary outcomes of substance use and utilization of relationship safety resources.

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Computer Intervention

Study Locations (1)

Rhode Island

  • Rhode Island Hospital Department of Emergency Medicine - Providence

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2012-03
Est. Completion 2014-11
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT01709552

The ClinicalTrials.gov registry entry for NCT01709552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (97% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT01709552 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01709552 about?

NCT01709552 is a clinical study titled "Brief Intervention for Substance Use and Partner Abuse Among Females in the ER". The purpose of this study is to target co-occurring problems of substance use and intimate partner violence (IPV) using a computer-based intervention, B-SAFER (Brief intervention for Substance use and partner Abuse for Females in the Emergency Room). This project will develop and test the computer-b...

What is the current status of trial NCT01709552?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-03. Estimated completion is 2014-11.

What conditions does trial NCT01709552 study?

This clinical trial studies the following conditions: Substance-Related Disorders, Domestic Violence.

What interventions are being tested in trial NCT01709552?

The interventions under investigation include: Control (BEHAVIORAL), Computer Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01709552?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01709552 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.